Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liching Cao

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Gene Therapy|July 1, 2022
Clinical enrollment assay to detect preexisting neutralizing antibodies to AAV6 with demonstrated transgene expression in gene therapy trialsLiching Cao, Annemarie Ledeboer, Yonghua Pan, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 19, 2015
A Novel Allosteric Insulin Receptor-Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus MonkeysPadma Bezwada, Jingsong Zhao, Ken Der, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2023
A sensitive AAV transduction inhibition assay assists evaluation of critical factors for detection and concordance of pre-existing antibodiesYonghua Pan, Michelle Rohde, Jennifer Zeitler, et al.
Nucleic Acids Research|September 10, 2004
Multiplex mRNA assay using electrophoretic tags for high-throughput gene expression analysisHuan Tian, Liching Cao, Yuping Tan, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate ReductionMakiko Yasuda, Marshall W Huston, Silvere Pagant, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 27, 2022
First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia BPaul Harmatz, Carlos E Prada, Barbara K Burton, et al.
Blood|October 23, 2023
Giroctocogene fitelparvovec gene therapy for severe hemophilia A: 104-week analysis of the phase 1/2 Alta studyAndrew D Leavitt, Barbara A Konkle, Kimo C Stine, et al.
The AAPS Journal|September 4, 2024
Correction to: Neutralizing Antibody Sample Testing and Report HarmonizationDarshana Jani, Michele Gunsior, Robin Marsden, et al.
The AAPS Journal|July 11, 2024
Neutralizing Antibody Sample Testing and Report HarmonizationDarshana Jani, Michele Gunsior, Robin Marsden, et al.
The AAPS Journal|October 28, 2022
Anti-drug Antibody Sample Testing and Reporting HarmonizationDarshana Jani, Robin Marsden, Michele Gunsior, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Gene Therapy|July 1, 2022
Clinical enrollment assay to detect preexisting neutralizing antibodies to AAV6 with demonstrated transgene expression in gene therapy trialsLiching Cao, Annemarie Ledeboer, Yonghua Pan, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 19, 2015
A Novel Allosteric Insulin Receptor-Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus MonkeysPadma Bezwada, Jingsong Zhao, Ken Der, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2023
A sensitive AAV transduction inhibition assay assists evaluation of critical factors for detection and concordance of pre-existing antibodiesYonghua Pan, Michelle Rohde, Jennifer Zeitler, et al.
Nucleic Acids Research|September 10, 2004
Multiplex mRNA assay using electrophoretic tags for high-throughput gene expression analysisHuan Tian, Liching Cao, Yuping Tan, et al.
Molecular Therapy. Methods & Clinical Development|August 11, 2020
AAV2/6 Gene Therapy in a Murine Model of Fabry Disease Results in Supraphysiological Enzyme Activity and Effective Substrate ReductionMakiko Yasuda, Marshall W Huston, Silvere Pagant, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 27, 2022
First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia BPaul Harmatz, Carlos E Prada, Barbara K Burton, et al.
Blood|October 23, 2023
Giroctocogene fitelparvovec gene therapy for severe hemophilia A: 104-week analysis of the phase 1/2 Alta studyAndrew D Leavitt, Barbara A Konkle, Kimo C Stine, et al.
The AAPS Journal|September 4, 2024
Correction to: Neutralizing Antibody Sample Testing and Report HarmonizationDarshana Jani, Michele Gunsior, Robin Marsden, et al.
The AAPS Journal|July 11, 2024
Neutralizing Antibody Sample Testing and Report HarmonizationDarshana Jani, Michele Gunsior, Robin Marsden, et al.
The AAPS Journal|October 28, 2022
Anti-drug Antibody Sample Testing and Reporting HarmonizationDarshana Jani, Robin Marsden, Michele Gunsior, et al.
Pageof 2